Skip to Main Content

Paper Details

When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.
Assay Drug Dev Technol
3
2017
Author NameAffiliation
Jill M Pulley1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Rebecca N Jerome1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Nicole M Zaleski1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Jana K Shirey-Rice1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Robert R Lavieri1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
David M AronoffVanderbilt University School of Medicine
David A EdwardsVanderbilt University School of Medicine
Leslie J CroffordVanderbilt University School of Medicine
Gordon R Bernard1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Kenneth J Holroyd1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Kenneth J Holroyd9 Center for Technology Transfer and Commercialization, Vanderbilt University
  • 1 - 11

Datasets

Release 1.2